Brainstorm Cell Therapeutics Inc (BCLI:OTCMKTS)
$0.695 0.07 (12.10%)
Analysed Brainstorm Cell Therapeutics Inc (BCLI:OTCMKTS) News Sources
Brainstorm Cell Therapeutics Secures Second $1 Million Strategic Placement; Total $2 Million Raised In February
Yahoo Finance
BrainStorm Cell Therapeutics Inc.: Brainstorm Cell Therapeutics Secures Second $1 Million Strategic Placement; Total $2 Million Raised In February
FinanzNachrichten.de
Brainstorm Cell Therapeutics Announces $1 Million Strategic Financing at Premium to Market
Yahoo Finance
Brainstorm Cell secures $1M strategic financing
Seeking Alpha
Brainstorm Cell Therapeutics Raises $1M in Private Placement
Precision Medicine Online
Compass Pathways Announces Exercise of $200 Million in Outstanding Warrants
Le Lézard
Cogent Communications Reports Fourth Quarter 2025 and Full Year 2025 Results
Le Lézard
Amyotrophic Lateral Sclerosis (ALS) Market Forecast 2026-2035 Trends, Therapeutic Advances, and Projected Revenue Growth
Taiwan News
Gilead to acquire cancer therapy developer Arcellx for up to $7.8 billion
The Economic Times
What is the current price of Brainstorm Cell Therapeutics Inc (BCLI:OTCMKTS)?
The current price of Brainstorm Cell Therapeutics Inc (BCLI:OTCMKTS) is $0.695.
Brainstorm Cell Therapeutics Inc (BCLI:OTCMKTS) absolute price change since previous trading day?
The absolute price change of Brainstorm Cell Therapeutics Inc (BCLI:OTCMKTS) since the previous trading day is $0.07.
Brainstorm Cell Therapeutics Inc (BCLI:OTCMKTS) percentage price change since previous trading day?
The percentage price change of Brainstorm Cell Therapeutics Inc (BCLI:OTCMKTS) since the previous trading day is 12.10%.
What is This Week's average sentiment score for Brainstorm Cell Therapeutics Inc (BCLI:OTCMKTS)?
This Week's average sentiment score for Brainstorm Cell Therapeutics Inc (BCLI:OTCMKTS) is 87 out of 100.
What is This Week's average sentiment for Brainstorm Cell Therapeutics Inc (BCLI:OTCMKTS)?
This Week's sentiment for Brainstorm Cell Therapeutics Inc (BCLI:OTCMKTS) is .
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.